Troya, J.; Pedrero-Tomé, R.; Buzón, L.; Dueñas, C.; on behalf of the SPADE Study Group.
Predict the Effects of Dolutegravir (DTG) Plus Lamivudine (3TC) on Immunological Responses in People Living with HIV (PLWHIV). J. Clin. Med. 2023, 12, 1176.
https://doi.org/10.3390/jcm12031176
AMA Style
Troya J, Pedrero-Tomé R, Buzón L, Dueñas C, on behalf of the SPADE Study Group.
Predict the Effects of Dolutegravir (DTG) Plus Lamivudine (3TC) on Immunological Responses in People Living with HIV (PLWHIV). Journal of Clinical Medicine. 2023; 12(3):1176.
https://doi.org/10.3390/jcm12031176
Chicago/Turabian Style
Troya, Jesús, Roberto Pedrero-Tomé, Luis Buzón, Carlos Dueñas, and on behalf of the SPADE Study Group.
2023. "Predict the Effects of Dolutegravir (DTG) Plus Lamivudine (3TC) on Immunological Responses in People Living with HIV (PLWHIV)" Journal of Clinical Medicine 12, no. 3: 1176.
https://doi.org/10.3390/jcm12031176
APA Style
Troya, J., Pedrero-Tomé, R., Buzón, L., Dueñas, C., & on behalf of the SPADE Study Group.
(2023). Predict the Effects of Dolutegravir (DTG) Plus Lamivudine (3TC) on Immunological Responses in People Living with HIV (PLWHIV). Journal of Clinical Medicine, 12(3), 1176.
https://doi.org/10.3390/jcm12031176